Pharmaceutical Export to Malaysia from India

Malaysia has an established pharmaceutical industry supported by healthcare demand, local manufacturing and international pharmaceutical trade. India is an important pharmaceutical trading partner for Malaysia. In 2025, India exported approximately US$124.77 million of pharmaceutical products to Malaysia.

Global Entra Pharma is an Indian pharmaceutical manufacturer offering selected finished pharmaceutical formulations for pharmaceutical companies, distributors and healthcare businesses in Malaysia.

Pharmaceutical Manufacturing for Malaysia

Global Entra Pharma specializes in selected pharmaceutical dosage forms, including:

• Pharmaceutical suppositories

• Vaginal pessaries

• Vaginal ovules

• Pharmaceutical creams

• Pharmaceutical ointments

Products can be manufactured according to the required composition, strength, specifications, packaging configuration and applicable Malaysian regulatory requirements.

Pharmaceutical Regulatory Authority in Malaysia

The National Pharmaceutical Regulatory Agency (NPRA) under Malaysia's Ministry of Health is responsible for pharmaceutical product regulation and registration.

NPRA administers the Drug Control Authority framework and maintains regulatory guidance for pharmaceutical product registration. Its current Drug Registration Guidance Document was updated in July 2026.

Pharmaceutical Registration in Malaysia

Pharmaceutical products intended for sale or marketing in Malaysia must comply with the applicable registration requirements. NPRA states that registered medicines receive a registration number beginning with MAL, which must appear on the product label or packaging.

For imported products, a foreign pharmaceutical company must appoint a Malaysian company as the local product registration holder. The local applicant is responsible for matters relating to the product registration.

Depending on the product and registration pathway, documentation may include:

• Product registration application

• Manufacturer information

• Manufacturing licence

• GMP documentation

• Qualitative and quantitative composition

• Manufacturing process

• Finished-product specifications

• Analytical methods

• Certificate of Analysis

• Stability data

• Packaging specifications

• Labelling and package insert

• CPP, where applicable

• FSC, where applicable

• Product samples, where required

The final requirements depend on the product classification and applicable NPRA pathway.

GMP Requirements for Imported Pharmaceutical Products

NPRA's registration guidance addresses GMP requirements for international manufacturers. Depending on the manufacturer's regulatory status and country, GMP inspection by NPRA may be required. NPRA also provides specific guidance for foreign GMP inspections.

For an Indian manufacturer, GMP documentation and manufacturing-site information should therefore be prepared according to the requirements applicable to the Malaysian registration application.

Pharmaceutical Import Requirements

Imported pharmaceutical products must comply with Malaysian registration, licensing and import requirements.

After product registration, the applicable manufacturer, import or wholesale licence must be obtained by the relevant regulated establishment.

Depending on the product and shipment, documentation may include:

• Commercial invoice

• Packing list

• Certificate of Origin

• Bill of Lading or Air Waybill

• Certificate of Analysis

• Manufacturing licence

• GMP certificate

• Product registration documentation

• CPP or other regulatory certificates

• Packaging and labelling information

The Malaysian importer and registration holder should verify the current requirements before commercial shipment.

Suppositories for Malaysia

Global Entra Pharma manufactures pharmaceutical suppositories for selected therapeutic applications. Different strengths, formulations and packaging configurations can be produced according to the agreed product specification.

Pessaries for Malaysia

Vaginal pessaries provide a specialized dosage form for women's healthcare. Selected formulations can be manufactured with suitable active ingredients, strengths, formulation bases and packaging configurations.

Vaginal Ovules for Malaysia

Vaginal ovules provide flexibility for women's healthcare formulations. Manufacturing can accommodate selected active ingredients, suitable bases, strengths and packaging formats according to the agreed specification.

Pharmaceutical Creams for Malaysia

Pharmaceutical creams are used across dermatological, anti-infective and other topical therapeutic categories. Selected formulations can be manufactured according to the required strength, formulation and packaging specifications.

Pharmaceutical Ointments for Malaysia

Pharmaceutical ointments provide a semisolid dosage form for various topical applications. Manufacturing can be planned around the required formulation, strength, packaging and quality specifications.

Quality and Regulatory Documentation

A suitable technical documentation package supports pharmaceutical registration and commercial supply. Depending on the product, it may include:

• Manufacturing licence

• GMP certificate

• Certificate of Analysis

• Product specifications

• Stability documentation

• Batch manufacturing documentation

• Packaging specifications

• CPP

• FSC

• Regulatory dossier

Documentation should be prepared according to the current NPRA requirements applicable to the specific product.

Private Label Pharmaceutical Manufacturing

Global Entra Pharma provides private-label manufacturing for selected pharmaceutical formulations. Buyers can specify composition, strength, packaging configuration, artwork and other technical requirements.

Private-label manufacturing enables pharmaceutical companies and distributors to develop products under their own approved brands while utilizing an Indian pharmaceutical manufacturing facility.

Contract Pharmaceutical Manufacturing from India

Global Entra Pharma supports contract manufacturing for selected finished pharmaceutical formulations.

Products can be manufactured according to agreed technical specifications, quality requirements, packaging configurations and applicable regulatory documentation.

For Malaysia, the responsibilities of the manufacturer, product registration holder, importer and other regulated parties should be established before commercial supply.

Pharmaceutical Export Process to Malaysia

A typical export process can include:

1. Product selection

2. Strength and quantity confirmation

3. Commercial quotation

4. Technical and regulatory review

5. Registration requirement assessment

6. Dossier preparation

7. Packaging and artwork approval

8. Manufacturing

9. Quality control and batch release

10. Export documentation

11. Shipment to Malaysia

The actual process depends on the product, registration status, local registration holder and applicable NPRA requirements.

Why Choose an Indian Pharmaceutical Manufacturer?

India is one of the world's major pharmaceutical manufacturing and export centres. Its pharmaceutical trade with Malaysia is well established, with India exporting approximately US$124.77 million of pharmaceutical products to Malaysia in 2025.

For Malaysian pharmaceutical buyers, manufacturing from India can provide access to specialized dosage forms, private-label production, customized packaging and structured pharmaceutical documentation.

Five Specialized Pharmaceutical Dosage Forms

Global Entra Pharma's specialized manufacturing portfolio includes:

• Suppositories

• Pessaries

• Vaginal ovules

• Pharmaceutical creams

• Pharmaceutical ointments

These dosage forms support applications across women's healthcare, dermatology, anti-infective therapy and other pharmaceutical categories.

Frequently Asked Questions

Can pharmaceutical products be exported from India to Malaysia?

Yes. India exported approximately US$124.77 million of pharmaceutical products to Malaysia in 2025.

Who regulates medicines in Malaysia?

The National Pharmaceutical Regulatory Agency (NPRA) under Malaysia's Ministry of Health is the principal pharmaceutical regulatory authority.

Is pharmaceutical registration required in Malaysia?

Yes. Pharmaceutical products must meet the applicable registration requirements before they can be marketed or sold in Malaysia. Registered products receive a MAL registration number.

Does an overseas manufacturer need a Malaysian registration holder?

Yes. NPRA states that a foreign company bringing pharmaceutical products into Malaysia must appoint a Malaysian company as the local product registration holder.

Can Global Entra Pharma manufacture private-label medicines for Malaysia?

Yes. Selected pharmaceutical formulations can be manufactured under private-label arrangements according to agreed specifications and applicable Malaysian requirements.

What documents may be required for registration?

Depending on the product, documentation may include manufacturing and GMP certificates, composition, specifications, analytical information, stability data, CoA, CPP, FSC, packaging information and product samples.

Pharmaceutical Export from India to Malaysia

Global Entra Pharma manufactures specialized pharmaceutical formulations for pharmaceutical buyers across Asian, African, Middle Eastern and other international markets. Its manufacturing portfolio includes suppositories, pessaries, vaginal ovules, pharmaceutical creams and ointments.

For pharmaceutical export to Malaysia, product registration, local registration-holder requirements, import procedures, labelling and technical documentation should be verified according to the current NPRA requirements applicable to the specific product.